About David Nichols
Form D filings for 2A Biosciences in 2023 list David Nichols as chief drug discovery officer and director.
David Nichols first appears on SEC filings in 2023.
Experience
This experience comes from SEC filings. The years are when the filings name David Nichols in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people David Nichols works with at each company, as listed on that company's latest Form D.
2A Biosciences, Inc. · Form D/A, Jul 27, 2023
GD
Gopal Das
Director
AS
Alexander Speiser
Chief Executive Officer and director
CN
Charles Nichols
Chief Scientific Officer and director
TF
Timothy Foster
Head of Research and director